Literature DB >> 21913060

High resolution MRI of the breast at 3 T: which BI-RADS® descriptors are most strongly associated with the diagnosis of breast cancer?

K Pinker-Domenig1, W Bogner, S Gruber, H Bickel, S Duffy, M Schernthaner, P Dubsky, U Pluschnig, M Rudas, S Trattnig, T H Helbich.   

Abstract

OBJECTIVE: To identify which breast lesion descriptors in the ACR BI-RADS® MRI lexicon are most strongly associated with the diagnosis of breast cancer when performing breast MR imaging at 3 T.
METHODS: 150 patients underwent breast MR imaging at 3 T. Lesion size, morphology and enhancement kinetics were assessed according to the BI-RADS® classification. Sensitivity, specificity and diagnostic accuracy were assessed. The effects of the BI-RADS® descriptors on sensitivity and specificity were evaluated. Data were analysed using logistic regression. Histopathological diagnoses were used as the standard of reference.
RESULTS: The sensitivity, specificity and diagnostic accuracy of breast MRI at 3 T was 99%, 81% and 93%, respectively. In univariate analysis, the final diagnosis of malignancy was positively associated with irregular shape (p < 0.001), irregular margin (p < 0.001), heterogeneous enhancement (p < 0.001), Type 3 enhancement kinetics (p = 0.02), increasing patient age (p = 0.02) and larger lesion size (p < 0.001). In multivariate analysis, significant associations with malignancy remained for mass shape (p = 0.06), mass margin (p < 0.001), internal enhancement pattern (p = 0.03) and Type 3 enhancement kinetics (p = 0.06).
CONCLUSION: The ACR BI-RADS® breast lesion descriptors that are mostly strongly associated with breast cancer in breast MR imaging at 3 T are lesion shape, lesion margin, internal enhancement pattern and Type 3 enhancement kinetics. KEY POINTS: • 3 Tesla breast MRI allows an accurate diagnosis of breast cancer • The BI-RADS® descriptors help provide a confident diagnosis • The shape, margin, enhancement pattern and kinetics are the most important features • An irregular shape and margin, heterogeneous enhancement and type-3 kinetics indicate malignancy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21913060     DOI: 10.1007/s00330-011-2256-6

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  42 in total

1.  Review of breast MRI: indications and limitations.

Authors:  E A Morris
Journal:  Semin Roentgenol       Date:  2001-07       Impact factor: 0.800

2.  Illustrated breast MR lexicon.

Authors:  E A Morris
Journal:  Semin Roentgenol       Date:  2001-07       Impact factor: 0.800

3.  Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions?

Authors:  C K Kuhl; P Mielcareck; S Klaschik; C Leutner; E Wardelmann; J Gieseke; H H Schild
Journal:  Radiology       Date:  1999-04       Impact factor: 11.105

4.  The role of MRI in invasive lobular carcinoma.

Authors:  Carla Boetes; Jeroen Veltman; Lya van Die; Peter Bult; Theo Wobbes; Jelle O Barentsz
Journal:  Breast Cancer Res Treat       Date:  2004-07       Impact factor: 4.872

5.  False-positive findings at contrast-enhanced breast MRI: a BI-RADS descriptor study.

Authors:  Pascal A T Baltzer; Matthias Benndorf; Matthias Dietzel; Mieczyslaw Gajda; Ingo B Runnebaum; Werner A Kaiser
Journal:  AJR Am J Roentgenol       Date:  2010-06       Impact factor: 3.959

6.  Dynamic bilateral contrast-enhanced MR imaging of the breast: trade-off between spatial and temporal resolution.

Authors:  Christiane K Kuhl; Hans H Schild; Nuschin Morakkabati
Journal:  Radiology       Date:  2005-09       Impact factor: 11.105

7.  Breast MR imaging at 3T.

Authors:  Christiane K Kuhl
Journal:  Magn Reson Imaging Clin N Am       Date:  2007-08       Impact factor: 2.266

8.  Probability of malignancy for lesions detected on breast MRI: a predictive model incorporating BI-RADS imaging features and patient characteristics.

Authors:  Wendy B Demartini; Brenda F Kurland; Robert L Gutierrez; C Craig Blackmore; Sue Peacock; Constance D Lehman
Journal:  Eur Radiol       Date:  2011-02-27       Impact factor: 5.315

9.  The value of high-field MRI (3T) in the assessment of sellar lesions.

Authors:  K Pinker; A Ba-Ssalamah; S Wolfsberger; V Mlynarik; E Knosp; S Trattnig
Journal:  Eur J Radiol       Date:  2005-06       Impact factor: 3.528

10.  Increasing accuracy of detection of breast cancer with 3-T MRI.

Authors:  Haitham Elsamaloty; Mohamed Salah Elzawawi; Shaden Mohammad; Nabeel Herial
Journal:  AJR Am J Roentgenol       Date:  2009-04       Impact factor: 3.959

View more
  22 in total

1.  Clinical application of bilateral high temporal and spatial resolution dynamic contrast-enhanced magnetic resonance imaging of the breast at 7 T.

Authors:  K Pinker; W Bogner; P Baltzer; S Trattnig; S Gruber; O Abeyakoon; M Bernathova; O Zaric; P Dubsky; Z Bago-Horvath; M Weber; D Leithner; T H Helbich
Journal:  Eur Radiol       Date:  2013-12-05       Impact factor: 5.315

2.  3.0 Tesla breast magnetic resonance imaging in patients with nipple discharge when mammography and ultrasound fail.

Authors:  Nóra Lubina; Ulla Schedelbeck; Anne Roth; Andreas Max Weng; Eva Geissinger; Arnd Hönig; Dietbert Hahn; Thorsten Alexander Bley
Journal:  Eur Radiol       Date:  2014-11-30       Impact factor: 5.315

3.  [Researcher of the month, December 2012. Dr. Wolfgang Bogner].

Authors:  Wolfgang Bogner
Journal:  Wien Klin Wochenschr       Date:  2012-12       Impact factor: 1.704

4.  Combined contrast-enhanced magnetic resonance and diffusion-weighted imaging reading adapted to the "Breast Imaging Reporting and Data System" for multiparametric 3-T imaging of breast lesions.

Authors:  K Pinker; H Bickel; T H Helbich; S Gruber; P Dubsky; U Pluschnig; M Rudas; Z Bago-Horvath; M Weber; S Trattnig; W Bogner
Journal:  Eur Radiol       Date:  2013-03-16       Impact factor: 5.315

5.  [Molecular breast imaging. An update].

Authors:  K Pinker; T H Helbich; H Magometschnigg; B Fueger; P Baltzer
Journal:  Radiologe       Date:  2014-03       Impact factor: 0.635

6.  Fat saturation in dynamic breast MRI at 3 Tesla: is the Dixon technique superior to spectral fat saturation? A visual grading characteristics study.

Authors:  P Clauser; K Pinker; T H Helbich; P Kapetas; M Bernathova; P A T Baltzer
Journal:  Eur Radiol       Date:  2014-05-04       Impact factor: 5.315

7.  Impact of an abbreviated protocol for breast MRI in diagnostic accuracy.

Authors:  Guillaume Oldrini; Imad Derraz; Julia Salleron; Frédéric Marchal; Philippe Henrot
Journal:  Diagn Interv Radiol       Date:  2018 Jan-Feb       Impact factor: 2.630

Review 8.  Proton MR spectroscopy in the breast: Technical innovations and clinical applications.

Authors:  Reza Fardanesh; Maria Adele Marino; Daly Avendano; Doris Leithner; Katja Pinker; Sunitha B Thakur
Journal:  J Magn Reson Imaging       Date:  2019-03-07       Impact factor: 4.813

Review 9.  Clinical role of breast MRI now and going forward.

Authors:  D Leithner; G J Wengert; T H Helbich; S Thakur; R E Ochoa-Albiztegui; E A Morris; K Pinker
Journal:  Clin Radiol       Date:  2017-12-09       Impact factor: 2.350

Review 10.  [Multiparametric and molecular imaging of breast tumors with MRI and PET/MRI].

Authors:  K Pinker; M A Marino; A Dr Meyer-Baese; T H Helbich
Journal:  Radiologe       Date:  2016-07       Impact factor: 0.635

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.